Pazopanib synergizes with docetaxel in the treatment of bladder cancer cells

OBJECTIVES: Bladder cancer expresses many potential therapeutic targets of biological agents including the vascular endothelial growth factor receptor (VEGFR). Pazopanib is a small molecule inhibitor of VEGFR-1, -2 -3, platelet derived growth factor receptor (PDGFR) and c-Kit. The current study inve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Li, Yuan, Yang, Xiaoping, Su, Lih-Jen, Flaig, Thomas W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126899/
https://ncbi.nlm.nih.gov/pubmed/21529900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2011.02.041
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge